RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism
Public ClinicalTrials.gov record NCT02596230. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Characterization of Patients Following Acute Venous Thromboembolism (VTE) and Safety and Effectiveness of Dabigatran Etexilate (DE) in the Treatment and Secondary Prevention of Acute Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in Comparison to Vitamin K Antagonist (VKA) in Routine Clinical Practice - RE-COVERY DVT/PE
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
RE-COVERY is a large, multi-national, multi-center observational study based on new data collection. The study will enroll and characterize patients within 30 days of being diagnosed with an acute DVT and/or PE. The study has two main objectives. Objective 1 will characterize the DVT / PE patient population. All patients with a DVT and/or PE will be enrolled for cross-sectional characterization of the VTE patient population. Objective 2 will compare the safety and effectiveness of dabigatran etexilate regimens for treatment of VTE in comparison to VKA regimens. Patients treated with dabigatran etexilate or VKA will be followed up for the occurrence of outcome events for up to one year.
Study identification
- NCT ID
- NCT02596230
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 7,797 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 5, 2015 (Actual)
- Primary completion
- Mar 31, 2019 (Actual)
- Completion
- Mar 31, 2019 (Actual)
- Last update posted
- Apr 29, 2020
2015 – 2019
United States locations
- U.S. sites
- 19
- U.S. states
- 12
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cardiovascular Innovation and Research Center | Long Beach | California | 90813 | — |
| Health and Life Research Institute, LLC | Miami | Florida | 33155 | — |
| Med-Care Research | Miami | Florida | 33165 | — |
| Pines Care Research Center | Pembroke Pines | Florida | 33026 | — |
| Tampa General Hospital | Tampa | Florida | 33606 | — |
| Ellipsis Group | Atlanta | Georgia | 30342 | — |
| Wellstar Cardiovascular Medicine | Marietta | Georgia | 30060 | — |
| Fox Valley Clinical Research Center, LLC | Aurora | Illinois | 60504 | — |
| Johns Hopkins University | Baltimore | Maryland | 21205 | — |
| Genesys Regional Medical Center | Grand Blanc | Michigan | 48439 | — |
| University Of Mississippi Medical Center | Jackson | Mississippi | 39216 | — |
| Vidant Multispecialty Clnc Kinston | Kinston | North Carolina | 28501 | — |
| Sanford Cardiology | Sanford | North Carolina | 27330 | — |
| Lycoming Internal Medicine, Inc | Jersey Shore | Pennsylvania | 17740 | — |
| Research Associates of Jackson | Jackson | Tennessee | 38301 | — |
| The University Of Texas at Houston | Houston | Texas | 77030 | — |
| Cardiology Center of Houston, PA | Katy | Texas | 77450 | — |
| Cardio Voyage | McKinney | Texas | 75071 | — |
| Waukesha Heart Institute | Waukesha | Wisconsin | 53188 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 203 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02596230, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 29, 2020 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02596230 live on ClinicalTrials.gov.